Literature DB >> 8675308

An in vitro model for sequential study of shiftdown of Mycobacterium tuberculosis through two stages of nonreplicating persistence.

L G Wayne1, L G Hayes.   

Abstract

It was demonstrated previously that abrupt transfer of vigorously aerated cultures of Mycobacterium tuberculosis to anaerobic conditions resulted in their rapid death, but gradual depletion of available O2 permitted expression of increased tolerance to anaerobiosis. Those studies used a model based on adaptation of unagitated bacilli as they settled through a self-generated O2 gradient, but the model did not permit examination of homogeneous populations of bacilli during discrete stages in that adaptation. The present report describes a model based on culture of tubercle bacilli in deep liquid medium with very gentle stirring that keeps them in uniform dispersion while controlling the rate at which O2 is depleted. In this model, at least two stages of nonreplicating persistence were seen. The shift into first stage, designated NRP stage 1, occurred abruptly at a point when the declining dissolved O2 level approached 1% saturation. This microaerophilic stage was characterized by a slow rate of increase in turbidity without a corresponding increase in numbers of CFU or synthesis of DNA. However, a high rate of production of glycine dehydrogenase was initiated and sustained while the bacilli were in this state, and a steady ATP concentration was maintained. When the dissolved O2 content of the culture dropped below about 0.06% saturation, the bacilli shifted down abruptly to an anaerobic stage, designated NRP stage 2, in which no further increase in turbidity was seen and the concentration of glycine dehydrogenase declined markedly. The ability of bacilli in NRP stage 2 to survive anaerobically was dependent in part on having spent sufficient transit time in NRP stage 1. The effects of four antimicrobial agents on the bacilli depended on which of the different physiologic stages the bacilli occupied at a given time and reflected the recognized modes of action of these agents. It is suggested that the ability to shift down into one or both of the two nonreplicating stages, corresponding to microaerophilic and anaerobic persistence, is responsible for the ability of tubercle bacilli to lie dormant in the host for long periods of time, with the capacity to revive and activate disease at a later time. The model described here holds promise as a tool to help clarify events at the molecular level that permit the bacilli to persist under adverse conditions and to resume growth when conditions become favorable. The culture model presented here is also useful for screening drugs for the ability to kill tubercle bacilli in their different stages of nonreplicating persistence.

Entities:  

Mesh:

Substances:

Year:  1996        PMID: 8675308      PMCID: PMC174037          DOI: 10.1128/iai.64.6.2062-2069.1996

Source DB:  PubMed          Journal:  Infect Immun        ISSN: 0019-9567            Impact factor:   3.441


  15 in total

1.  Enzyme systems in the mycobacteria. XIII. Glycine dehydrogenase and the glyoxylic acid cycle.

Authors:  D S GOLDMAN; M J WAGNER
Journal:  Biochim Biophys Acta       Date:  1962-12-04

Review 2.  Dormancy of Mycobacterium tuberculosis and latency of disease.

Authors:  L G Wayne
Journal:  Eur J Clin Microbiol Infect Dis       Date:  1994-11       Impact factor: 3.267

Review 3.  Mechanism of antimicrobial action of metronidazole.

Authors:  D I Edwards
Journal:  J Antimicrob Chemother       Date:  1979-09       Impact factor: 5.790

Review 4.  Dormancy in non-sporulating bacteria.

Authors:  A S Kaprelyants; J C Gottschal; D B Kell
Journal:  FEMS Microbiol Rev       Date:  1993-04       Impact factor: 16.408

5.  Evidence for the generation of active oxygen by isoniazid treatment of extracts of Mycobacterium tuberculosis H37Ra.

Authors:  H A Shoeb; B U Bowman; A C Ottolenghi; A J Merola
Journal:  Antimicrob Agents Chemother       Date:  1985-03       Impact factor: 5.191

6.  Quantitative extraction of adenosine triphosphate from cultivable and host-grown microbes: calculation of adenosine triphosphate pools.

Authors:  A M Dhople; J H Hanks
Journal:  Appl Microbiol       Date:  1973-09

7.  Glyoxylate metabolism and adaptation of Mycobacterium tuberculosis to survival under anaerobic conditions.

Authors:  L G Wayne; K Y Lin
Journal:  Infect Immun       Date:  1982-09       Impact factor: 3.441

8.  Effect of isoniazid on the in vivo mycolic acid synthesis, cell growth, and viability of Mycobacterium tuberculosis.

Authors:  K Takayama; L Wang; H L David
Journal:  Antimicrob Agents Chemother       Date:  1972-07       Impact factor: 5.191

9.  Metronidazole is bactericidal to dormant cells of Mycobacterium tuberculosis.

Authors:  L G Wayne; H A Sramek
Journal:  Antimicrob Agents Chemother       Date:  1994-09       Impact factor: 5.191

10.  Amplification and nucleotide sequence of the quinolone resistance-determining region in the gyrA gene of mycobacteria.

Authors:  E Cambau; W Sougakoff; V Jarlier
Journal:  FEMS Microbiol Lett       Date:  1994-02-01       Impact factor: 2.742

View more
  457 in total

1.  Proteins of Mycobacterium bovis BCG induced in the Wayne dormancy model.

Authors:  C Boon; R Li; R Qi; T Dick
Journal:  J Bacteriol       Date:  2001-04       Impact factor: 3.490

2.  A cooperative oxygen-binding hemoglobin from Mycobacterium tuberculosis.

Authors:  M Couture; S R Yeh; B A Wittenberg; J B Wittenberg; Y Ouellet; D L Rousseau; M Guertin
Journal:  Proc Natl Acad Sci U S A       Date:  1999-09-28       Impact factor: 11.205

3.  The stringent response of Mycobacterium tuberculosis is required for long-term survival.

Authors:  T P Primm; S J Andersen; V Mizrahi; D Avarbock; H Rubin; C E Barry
Journal:  J Bacteriol       Date:  2000-09       Impact factor: 3.490

4.  In vitro activities of mitomycin C against growing and hypoxic dormant tubercle bacilli.

Authors:  H L Peh; A Toh; B Murugasu-Oei; T Dick
Journal:  Antimicrob Agents Chemother       Date:  2001-08       Impact factor: 5.191

5.  Microaerophilic induction of the alpha-crystallin chaperone protein homologue (hspX) mRNA of Mycobacterium tuberculosis.

Authors:  L E Desjardin; L G Hayes; C D Sohaskey; L G Wayne; K D Eisenach
Journal:  J Bacteriol       Date:  2001-09       Impact factor: 3.490

Review 6.  Tuberculosis: latency and reactivation.

Authors:  J L Flynn; J Chan
Journal:  Infect Immun       Date:  2001-07       Impact factor: 3.441

7.  Metronidazole therapy in mice infected with tuberculosis.

Authors:  J V Brooks; S K Furney; I M Orme
Journal:  Antimicrob Agents Chemother       Date:  1999-05       Impact factor: 5.191

8.  Localization of acidic phospholipid cardiolipin and DnaA in mycobacteria.

Authors:  Erin Maloney; Sai Chandana Madiraju; Malini Rajagopalan; Murty Madiraju
Journal:  Tuberculosis (Edinb)       Date:  2011-12-03       Impact factor: 3.131

9.  Mycobacterium bovis BCG response regulator essential for hypoxic dormancy.

Authors:  Calvin Boon; Thomas Dick
Journal:  J Bacteriol       Date:  2002-12       Impact factor: 3.490

10.  Sterilizing activities of fluoroquinolones against rifampin-tolerant populations of Mycobacterium tuberculosis.

Authors:  Yanmin Hu; Anthony R M Coates; Denis A Mitchison
Journal:  Antimicrob Agents Chemother       Date:  2003-02       Impact factor: 5.191

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.